Eltrombopag Olamine Tablets 50 mg | LTROLAMINE 50

Description

LTROLAMINE 50 contains Eltrombopag Olamine Tablets 50 mg, a clinically proven oral medicine used to manage low platelet count (thrombocytopenia). Platelets play a vital role in blood clotting, and reduced platelet levels can increase the risk of bleeding and bruising. LTROLAMINE 50 is commonly prescribed in specific blood-related disorders where platelet production is insufficient. Developed with strict quality standards, this medicine helps stimulate platelet production in the bone marrow, supporting safer platelet levels and improving patient outcomes. It is widely used under medical supervision as part of long-term or condition-specific treatment plans. Uses of LTROLAMINE 50 LTROLAMINE 50 is primarily used in the treatment of conditions associated with low platelet count, including: Chronic Immune Thrombocytopenia (ITP) in adults who do not respond adequately to corticosteroids or immunoglobulins Severe Aplastic Anaemia, where bone marrow fails to produce enough blood cells Thrombocytopenia associated with chronic hepatitis C, especially in patients requiring antiviral therapy By increasing platelet production, LTROLAMINE 50 helps reduce bleeding risk and supports continuity of essential treatments. Benefits of Eltrombopag Olamine Tablets 50 mg LTROLAMINE 50 offers several therapeutic benefits: Helps increase and maintain platelet count within a safer range Reduces the risk of spontaneous bleeding and bruising Oral tablet form ensures convenient and non-invasive administration Supports patients requiring ongoing treatment where low platelets limit therapy options Clinically validated molecule with predictable and targeted action Regular monitoring ensures effective and safe long-term use as advised by healthcare professionals. Dosage The dosage of LTROLAMINE 50 should always be decided by a doctor based on the patient’s medical condition, platelet levels, and response to treatment. Usually taken once daily, preferably on an empty stomach Avoid taking it with dairy products, calcium supplements, or iron-rich foods as they may reduce absorption Dosage adjustments may be required based on blood test results Patients should not change the dose or stop the medicine without medical advice. Side Effects Like all medicines, LTROLAMINE 50 may cause some side effects, although not everyone experiences them. Commonly reported side effects include: Headache or fatigue Nausea or stomach discomfort Increased liver enzymes in blood tests Muscle pain or body aches Rare but serious side effects may include liver-related issues or blood clotting problems. Regular blood tests are essential to monitor platelet levels and liver function during treatment. Precautions and Warning Before starting LTROLAMINE 50, patients should inform their doctor about any existing medical conditions, especially liver disease, blood clotting disorders, or pregnancy. Not recommended for self-medication Use with caution in patients with liver impairment Regular monitoring of platelet count and liver function is mandatory Pregnant or breastfeeding women should use it only if clearly prescribed Do not combine with supplements containing calcium, magnesium, or iron without medical guidance Following medical instructions strictly helps ensure safety and effectiveness. Conclusion LTROLAMINE 50 (Eltrombopag Olamine Tablets 50 mg) is a trusted therapeutic option for managing thrombocytopenia associated with chronic blood disorders. By stimulating platelet production, it plays a crucial role in reducing bleeding risks and improving quality of life. With proper medical supervision, regular monitoring, and adherence to prescribed guidelines, LTROLAMINE 50 offers reliable support for patients requiring sustained platelet management. Always consult a healthcare professional for personalised advice and optimal treatment outcomes.